25th July 2019 – Clinical
Decision Support Systems Market study offers detail overview of industry
with all the requisite data to support tactical business decisions and come up
with strategic growth plans. This study also proposes a comprehensive insight
into the development policies and plans in addition to manufacturing processes
and cost structures.
Global Clinical Decision Support Systems
Market is expected to reach USD 791.25 million by 2024. Clinical Decision
Support System is also termed, as CDSS is an application that recognizes data
to support healthcare providers make clinical decisions. It is a version of the
decision support system exclusively used to support business management. To
prepare a diagnosis and evaluation of the diagnosis as a means of refining the
concluding result.
The Clinical Decision Support
System (CDSS) Market is estimated to grow at a significant CAGR of 6.7% over
the future period as the scope and its applications are rising enormously
across the globe.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/clinical-decision-support-systems-cdss-market/request-sample
The increasing government initiatives,
growing aging population, acceptance of HCIT solutions in healthcare, and
growing number of people suffering from chronic diseases are documented as
major factors of clinical decision support systems industry that are estimated
to enhance the growth in the years to come. However, saturated end-user market
and lack of skilled personnel are the factors that may restrain overall market
growth in the forecast period. Clinical Decision Support System industry is
segmented based on types, product types, delivery mode, components, user
inactivity, application, and region.
Diagnostics CDSS and Standalone CDSS are
the types that could be explored in Clinical Decision Support System in the
years to come. There are various product types of Clinical Decision Support
System that could be explored in forecast period are Integrated CDSS with CPOE
& E.H.R., Standalone CDSS, Integrated E.H.R. with CDSS, Integrated CPOE
with CDSS, and others. Clinical Decision Support System integrated with CPOE
segment accounts for the largest market share of overall market and is
estimated to lead the market in the coming years. Moreover, it is estimated to
grow at highest CAGR in the upcoming years. This may be because of, acceptance
of computerized prescription patterns in developed regions.
The market is categorized based on
delivery mode like On-Premises Delivery, Web Delivery, Cloud Delivery, and
others. On-premises mode is exclusively preferred due to information safety and
privacy issues. It is estimated to lead the overall market in the years to
come. Also, cloud-based delivery segment is estimated to grow at highest CAGR
in the upcoming years.
The software sector is at topmost
position due to the need for intervallic software upgradation. However,
Services and Hardware are other components that could be explored in Clinical
Decision Support System in the future period. The services may include
Post-sale and Maintenance Services, Consulting Services, Training and Education
Services, and Ongoing IT support and Implementation Services.
Passive CDSS and Active CDSS are the
user interactivity that could be explored in Clinical Decision Support System
in the upcoming years. Also, the market is categorized based on applications
like Drug Dosing Support, Drug-Drug Interactions, Clinical Guidelines, Drug
Allergy Alerts, Clinical Reminders, and others. The drug allergy alerts sector
is estimated to lead the overall market in the foremost period. However, drug
dosing support and drug-drug interactions follow suit.
Globally, North America accounts for the
largest market share of Clinical Decision Support System and is estimated to
remain dominant in the years to come. The reason behind the growth of market in
this region could be, rising importance on quality of healthcare services,
technological enhancement, and presence of reimbursement policies. The United
States may be a major consumer of Clinical Decision Support System in this
region in forecast period. Instead, Europe and the Asia Pacific are also
estimated to have a positive influence on the future growth.
However, Asia Pacific is estimated to
grow at fastest pace with the highest CAGR of 7.8% in the years to come. The
aspects that may be ascribed to the growth comprise, increasing investments in
the healthcare sector in countries like Singapore, Australia, India, and China.
In addition, developing countries like India and China are the major consumers
of Clinical Decision Support System in this region.
The key players of Clinical Decision
Support System Market are Siemens Healthcare, EPIC Systems Corporation Inc.,
Phillips Healthcare, International Business Machines (IBM), Cerner Corporation,
Elsevier B.V., McKesson Corporation, Zynx Health, Medical Information
Technology, Inc., Wolters Kluwer Health, and Allscripts Healthcare Solutions.
These players are concentrating on inorganic growth to sustain themselves
amongst fierce competition. As such, mergers, acquisitions, and joint ventures
are the need of the hour.
For
More Details, Visit @ http://www.millioninsights.com
No comments:
Post a Comment